000127224 001__ 127224
000127224 005__ 20240228140912.0
000127224 0247_ $$2doi$$a10.1016/j.radonc.2015.03.022
000127224 0247_ $$2pmid$$apmid:25842968
000127224 0247_ $$2ISSN$$a0167-8140
000127224 0247_ $$2ISSN$$a1879-0887
000127224 0247_ $$2altmetric$$aaltmetric:3867707
000127224 037__ $$aDKFZ-2017-03249
000127224 041__ $$aeng
000127224 082__ $$a610
000127224 1001_ $$aNischwitz, Sebastian P$$b0
000127224 245__ $$aClinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma.
000127224 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2015
000127224 3367_ $$2DRIVER$$aarticle
000127224 3367_ $$2DataCite$$aOutput Types/Journal article
000127224 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1522332955_8698
000127224 3367_ $$2BibTeX$$aARTICLE
000127224 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000127224 3367_ $$00$$2EndNote$$aJournal Article
000127224 520__ $$aThe physical and biological properties of ion-beams offer various advantages in comparison to conventional radiotherapy, though uncertainties concerning quality assurance are still left. Due to the inverted depth dose profile, range accuracy is of paramount importance. We investigated the range deviations between planning simulation and post-fractional PET/CT measurement from particle therapy in primary glioblastoma.20 patients with glioblastoma undergoing particle therapy at our institution were selected. 10 received a proton-boost, 10 a carbon-ion-boost in addition to standard treatment. After two fractions, we performed a PET/CT-scan of the brain. We compared the resulting range deviation based on the Most-likely-shift method between the two measurements, and the measurements with corresponding expectations, calculated with the Monte-Carlo code FLUKA.A patient's two measurements deviated by 0.7mm (±0.7mm). Overall comparison between measurements and simulation resulted in a mean range deviation of 3.3mm (±2.2mm) with significant lower deviations in the (12)C-arm.The used planning concepts display the actual dose distributions adequately. The carbon ion group's results are below the used PTV safety margins (3mm). Further adjustments to the simulation are required for proton irradiations. Some anatomical situations require particular attention to ensure highest accuracy and safety.
000127224 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000127224 588__ $$aDataset connected to CrossRef, PubMed,
000127224 7001_ $$aBauer, Julia$$b1
000127224 7001_ $$aWelzel, Thomas$$b2
000127224 7001_ $$aRief, Harald$$b3
000127224 7001_ $$0P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44$$aJäkel, Oliver$$b4$$udkfz
000127224 7001_ $$aHaberer, Thomas$$b5
000127224 7001_ $$aFrey, Kathrin$$b6
000127224 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b7$$udkfz
000127224 7001_ $$aParodi, Katia$$b8
000127224 7001_ $$aCombs, Stephanie E$$b9
000127224 7001_ $$aRieken, Stefan$$b10
000127224 773__ $$0PERI:(DE-600)1500707-8$$a10.1016/j.radonc.2015.03.022$$gVol. 115, no. 2, p. 179 - 185$$n2$$p179 - 185$$tRadiotherapy and oncology$$v115$$x0167-8140$$y2015
000127224 909CO $$ooai:inrepo02.dkfz.de:127224$$pVDB
000127224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000127224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000127224 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000127224 9141_ $$y2015
000127224 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000127224 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOTHER ONCOL : 2015
000127224 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000127224 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000127224 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000127224 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000127224 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000127224 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000127224 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000127224 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000127224 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000127224 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000127224 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000127224 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000127224 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lMedizinische Physik in der Strahlentherapie$$x0
000127224 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lKKE Strahlentherapie$$x1
000127224 980__ $$ajournal
000127224 980__ $$aVDB
000127224 980__ $$aI:(DE-He78)E040-20160331
000127224 980__ $$aI:(DE-He78)E050-20160331
000127224 980__ $$aUNRESTRICTED